Location History:
- Mckinnon, AU (2014)
- West Brunswick, AU (2023)
Company Filing History:
Years Active: 2014-2023
Title: David K Gardner: Innovator in Embryo Culture Media
Introduction
David K Gardner is a notable inventor based in McKinnon, Australia. He has made significant contributions to the field of reproductive biology, particularly in the development of culture media for embryos and stem cells. With a total of 2 patents, Gardner's work has the potential to enhance in vitro fertilization techniques and improve outcomes for developmental cells.
Latest Patents
Gardner's latest patents include innovative formulations for culture media. One patent focuses on a culture medium that comprises acetyl-carnitine and lipoic acid, which are crucial for the growth of embryos, gametes, or stem cells. The medium is designed to contain acetyl-carnitine at a concentration of about 5 to about 50 µM and lipoic acid at a concentration of about 2.5 to about 40 µM. Additionally, it may optionally include acetyl-cysteine at a similar concentration range. Another patent addresses culture media for developmental cells that utilize elevated concentrations of lipoic acid. This invention provides a method for in vitro fertilization that enhances the survival and development of blastocysts, leading to increased cell numbers and improved inner cell mass.
Career Highlights
David K Gardner is associated with Vitrolife Sweden AB, a company known for its advancements in reproductive technology. His work at Vitrolife has allowed him to focus on developing innovative solutions that support embryo development and improve the success rates of fertility treatments.
Collaborations
Gardner has collaborated with notable colleagues such as Thi Truong and Mark G Larman. These collaborations have contributed to the advancement of research in the field of reproductive biology and have helped in the development of effective culture media.
Conclusion
David K Gardner's contributions to the field of reproductive biology through his innovative patents and work at Vitrolife Sweden AB highlight his commitment to improving in vitro fertilization techniques. His research continues to pave the way for advancements in embryo culture media, ultimately benefiting the field of reproductive health.